Shopping Cart
- Remove All
Your shopping cart is currently empty
Sarizotan 2HCl is an hERG channel inhibitor and 5-hydroxytryptamine 5-HT1A receptor agonist with potential antidepressant effects for the study of Parkinsonian movement disorders.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $195 | In Stock | |
| 5 mg | $483 | In Stock | |
| 10 mg | $692 | In Stock | |
| 25 mg | $1,080 | In Stock | |
| 50 mg | $1,490 | In Stock | |
| 100 mg | $1,970 | In Stock |
| Description | Sarizotan 2HCl is an hERG channel inhibitor and 5-hydroxytryptamine 5-HT1A receptor agonist with potential antidepressant effects for the study of Parkinsonian movement disorders. |
| Targets&IC50 | 5-HT1A receptor:0.1 nM, 5-HT7 receptor (human):10 nM, 5-HT2A receptor:587 nM, 5-HT6 receptor (human):3300 nM, D3 receptor (human):6.8 nM, 5-HT2B receptor:108 nM, 5-HT5A receptor:313 nM |
| In vivo | Compared to rats treated with levodopa alone, Sarizotan 2HCl (10 ng and 1 μg in 0.3 μL solution) administered subthalamicly at higher doses (10 ng and 1 μg) significantly reduced rotational response scores in male Sprague-Dawley rats weighing 220-240 g. |
| Molecular Weight | 421.34 |
| Formula | C22H23Cl2FN2O |
| Cas No. | 177976-12-4 |
| Smiles | FC(C=C1)=CC=C1C2=CN=CC(CNC[C@@H]3OC4=CC=CC=C4CC3)=C2.Cl.Cl |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.